
Last updated: 2026-10-19 20:21:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Advanced Biomed Inc. (ADVB) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $4.18, with a market capitalization of $6.58M and a P/E ratio of 0.98. Over the past 52 weeks, its price has ranged from $3.61 to $24.23. This page covers its latest market performance, valuation, price trends and company information.
$6.58M | |
$3.93 | |
$82.00 | |
$3.61 | |
$3.98 | |
394.66K | |
891.83K | |
0.98 | |
$24.23 | |
$3.61 | |
-- | |
-- |
Advanced Biomed Inc. (ADVB) is trading at $4.18 in after-hours trading as of 2026-10-19 20:19:00, up 4.90% ($0.19) from the regular-session close of $3.98.
After-hours trading shows how investors are pricing ADVB after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Advanced Biomed Inc. (ADVB) moved from $6.12 to $4.18, representing a decline of 31.78% ($1.95).
The stock traded between $3.69 and $6.33 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 15.82 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.7%
ADVB is currently trading at $4.18, placing it 2.7% of the way from its 52-week low of $3.61 to its 52-week high of $24.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Advanced Biomed Inc operates through its subsidiary as an AI financial verification company focused on financial verification and other professional, regulated use cases. The Group develops and operates the FinTruth Financial Verification Agent Platform (FinTruth), an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. It focuses on establishing recurring and usage-based enterprise revenue from its AI technology operations. The Group has one reportable segment, consisting mainly of its technology and software-related operations.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 12 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Advanced Biomed Inc. (ADVB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.